Literature DB >> 11044805

A novel nonsense mutation of the KAL gene in two brothers with Kallmann syndrome.

C Jansen1, B I Hendriks-Stegeman, M Jansen.   

Abstract

Kallmann syndrome (KS), defined by the association of hypogonadotropic hypogonadism and anosmia or hyposmia, can be caused by mutations in the KAL gene on Xp 22.3. This gene encodes an extracellular matrix glycoprotein called anosmin-1, which belongs to the class of cell adhesion molecules. In the absence of a functional KAL protein, migration of both olfactory and gonadotropin-releasing hormone neurons is arrested. A defective anosmin-1 molecule may also play a role in the development of synkinesia and renal agenesis, which are exclusively seen in the X-linked form of KS. We describe the clinical presentation and molecular diagnosis of the defect in two brothers with KS. An X-linked mode of transmission was assumed on the basis of synkinesia and the presence of oligomenorrhoea in the mother. A novel nonsense mutation was found in exon 13 of the KAL gene, encoding the region of the fourth fibronectin type III repeat of anosmin-1, which results in an apparently nonfunctional truncated protein. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044805     DOI: 10.1159/000023568

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

Review 1.  Kallmann syndrome: fibroblast growth factor signaling insufficiency?

Authors:  Catherine Dodé; Jean-Pierre Hardelin
Journal:  J Mol Med (Berl)       Date:  2004-09-08       Impact factor: 4.599

2.  A novel nonsense mutation of the KAL1 gene (p.Trp204*) in Kallmann syndrome.

Authors:  Antonette Souto El Husny; Milene Raiol-Moraes; Milena Coelho Fernandes-Caldato; Andrea Ribeiro-Dos-Santos
Journal:  Appl Clin Genet       Date:  2014-09-30

3.  Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD).

Authors:  Mark J McCabe; Youli Hu; Louise C Gregory; Carles Gaston-Massuet; Kyriaki S Alatzoglou; José W Saldanha; Angelica Gualtieri; Ajay Thankamony; Ieuan Hughes; Sharron Townshend; Juan-Pedro Martinez-Barbera; Pierre-Marc Bouloux; Mehul T Dattani
Journal:  Mol Cell Endocrinol       Date:  2015-09-14       Impact factor: 4.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.